Indian Pharmacopoeia Commission

1 min read
Indian Pharmacopoeia Commission Blog Image


Recently, the pharma standards body Indian Pharmacopoeia Commission (IPC) has issued a drug safety alert over nimesulide, saying the pill can trigger rashes on the skin (fixed drug eruption).

About Indian Pharmacopoeia Commission

  • It is an autonomous Institution of the Ministry of Health and Family Welfare, Govt. of India.
  • It is created to set standards of drugs in the country.
  • Functions:
    • Its basic function is to update regularly the standards of drugs commonly required for treatment of diseases prevailing in this region.
    • It publishes official documents for improving Quality of Medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP).
    • It further promotes rational use of generic medicines by publishing National Formulary of India.
    • It prescribes standards for identity, purity and strength of drugs essentially required from the health care perspective of human beings and animals.
    • It also provides IP Reference Substances (IPRS) which act as a fingerprint for identification of an article under test and its purity as prescribed in IP.

What is a fixed drug eruption?

It is a distinctive variant of drug-induced dermatoses with characteristic recurrence at the same site of the skin or mucous membranes. 

It is known to occur more frequently with antimicrobials and nonsteroidal anti-inflammatory drugs than with other drugs.

Q1: What is Generic Drug?

It is a medication that has exactly the same active ingredient as the brand-name drug and yields the same therapeutic effect.

Source: IPC issues alert on painkiller drug nimesulide over adverse reaction